+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Rotary-Cutting Biopsy System for Breast Lesion Market by Guidance Technique (Ct, Mri, Stereotactic), Product Type (Disposable Blades, Reusable Handles), End User, Lesion Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081366
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Rotary-cutting biopsy systems for breast lesions are rapidly changing the diagnostic landscape, offering healthcare organizations innovative, minimally invasive solutions for tissue sampling. This market’s continuous advancements position it as a key focal point for industry leaders seeking clinical precision, operational efficiency, and strategic growth in breast cancer diagnostics.

Market Snapshot: Rotary-Cutting Biopsy System Market for Breast Lesions

The global market for rotary-cutting biopsy systems targeting breast lesions is experiencing robust growth, fueled by expanding cancer screening programs, technological advancements, and rising procedural volumes. With a substantial market size and an attractive CAGR, this segment is drawing increased investment from top-tier device manufacturers, healthcare providers, and distributors. Innovations in imaging guidance, automation, and AI-driven instrumentation are transforming diagnostic workflows, broadening access to care, and reshaping procurement strategies. These systems now anchor early-stage diagnostic pathways in ambulatory, diagnostic, and hospital settings.

Scope & Segmentation: Comprehensive Coverage and Strategic Depth

  • Guidance Techniques: Including CT, MRI, stereotactic (automated, manual), and ultrasound (portable, stationary) for tailored diagnostic interventions.
  • Product Types: Disposable blades for seamless workflow and sterility, and reusable handles for optimized asset management.
  • End User Categories: Encompassing ambulatory surgical centers (clinic-based, standalone), diagnostic centers (hospital-affiliated, independent), and hospitals (private, public).
  • Lesion Types: Addressing cystic lesions, microcalcifications, non-palpable, and palpable masses for comprehensive clinical applicability.
  • Distribution Channels: Direct sales for system customization and support, plus distributors (online, value-added) to extend reach and service capabilities.
  • Regions: Americas (United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, Southeast Asian nations).
  • Key Companies: Hologic, Becton, Dickinson and Company, Devicor Medical Products, Merit Medical, Argon Medical Devices, Cook Medical, Cardinal Health, Terumo, Misonix, Medtronic.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Technology convergence in rotary-cutting biopsy systems enhances diagnostic confidence and reduces procedure times, promoting broad adoption across clinical settings.
  • Automation, real-time imaging, and ergonomic improvements are streamlining operational workflows, supporting clinician efficiency and consistency in outcomes.
  • Patient-centered innovations are prioritizing safety and comfort, contributing to greater acceptance and demand in ambulatory and diagnostic center environments.
  • Market competition is intensifying, with suppliers differentiating on modularity, integrated AI features, and flexible sourcing to secure key contracts and sustain margins.
  • Robust service agreements and consumable models are emerging as critical revenue streams, reinforcing ongoing engagement between manufacturers and provider networks.

Tariff Impact: Navigating US Duties and Sourcing Strategies

New US tariffs on select medical device imports, effective from early 2025, have begun affecting rotary-cutting biopsy system supply chains. Manufacturers are responding by revising procurement, securing regional manufacturing, and entering long-term domestic supplier agreements. Healthcare providers emphasize transparent pricing models that account for service, consumables, and maintenance. Strategic adaptation to tariffs is now essential for resilient supply and operational continuity.

Methodology & Data Sources

This report applies a robust, multi-stage research methodology combining primary inputs from industry experts and clinicians with secondary analysis from published studies, financials, regulatory documents, and patent filings. Cross-validation and analytical frameworks ensure accuracy and actionable insights for stakeholders.

Why This Report Matters for Stakeholders

  • Offers strategic clarity for investment, procurement, and R&D by mapping emerging clinical, technological, and regulatory trends.
  • Enables decision-makers to benchmark competitors, assess tariff impacts, and identify growth markets across all major regions.
  • Facilitates operational planning by detailing segmentation, distribution options, and end-user behaviors critical to revenue optimization.

Conclusion

Rotary-cutting biopsy systems for breast lesions represent a dynamic, innovation-driven market where emerging clinical needs, supply chain resilience, and patient-focused design drive adoption. This report equips industry leaders with the perspective and tools needed to navigate, compete, and seize opportunities in this evolving field.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of real-time imaging modalities with rotary-cutting biopsy devices for enhanced lesion targeting
5.2. Adoption of automated tissue sample handling features to reduce procedural variability and increase throughput
5.3. Development of ultra-thin gauge rotary-cutting needles for minimally invasive sampling of small breast lesions
5.4. Rising implementation of MRI-compatible rotary-cutting biopsy systems for precise lesion localization
5.5. Emerging trend of AI-driven image analysis integration to guide needle trajectory and improve diagnostic yield
5.6. Expansion of point-of-care portable rotary-cutting biopsy units for outpatient and remote breast lesion assessment
5.7. Increasing focus on disposable sterile needle components to minimize cross-contamination risks and streamline workflows
5.8. Collaboration between device manufacturers and cloud platform providers for secure patient data management post biopsy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rotary-Cutting Biopsy System for Breast Lesion Market, by Guidance Technique
8.1. Introduction
8.2. Ct
8.3. Mri
8.4. Stereotactic
8.4.1. Automated Stereotactic
8.4.2. Manual Stereotactic
8.5. Ultrasound
8.5.1. Portable Ultrasound
8.5.2. Stationary Ultrasound
9. Rotary-Cutting Biopsy System for Breast Lesion Market, by Product Type
9.1. Introduction
9.2. Disposable Blades
9.3. Reusable Handles
10. Rotary-Cutting Biopsy System for Breast Lesion Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Clinic Based Ambulatory Surgical Centers
10.2.2. Standalone Ambulatory Surgical Centers
10.3. Diagnostic Centers
10.3.1. Hospital Affiliated Diagnostic Centers
10.3.2. Standalone Diagnostic Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Rotary-Cutting Biopsy System for Breast Lesion Market, by Lesion Type
11.1. Introduction
11.2. Cystic Lesions
11.3. Microcalcifications
11.4. Non Palpable Lesions
11.5. Palpable Lesions
12. Rotary-Cutting Biopsy System for Breast Lesion Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.3.1. Online Distributors
12.3.2. Value Added Distributors
13. Americas Rotary-Cutting Biopsy System for Breast Lesion Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Rotary-Cutting Biopsy System for Breast Lesion Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Hologic, Inc.
16.3.2. Becton, Dickinson and Company
16.3.3. Devicor Medical Products, Inc.
16.3.4. Merit Medical Systems, Inc.
16.3.5. Argon Medical Devices, Inc.
16.3.6. Cook Medical LLC
16.3.7. Cardinal Health, Inc.
16.3.8. Terumo Corporation
16.3.9. Misonix, Inc.
16.3.10. Medtronic plc
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET: RESEARCHAI
FIGURE 26. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET: RESEARCHSTATISTICS
FIGURE 27. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET: RESEARCHCONTACTS
FIGURE 28. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATED STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATED STEREOTACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MANUAL STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MANUAL STEREOTACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PORTABLE ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PORTABLE ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATIONARY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATIONARY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISPOSABLE BLADES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISPOSABLE BLADES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REUSABLE HANDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REUSABLE HANDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CLINIC BASED AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CLINIC BASED AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITAL AFFILIATED DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITAL AFFILIATED DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CYSTIC LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CYSTIC LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MICROCALCIFICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MICROCALCIFICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY NON PALPABLE LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY NON PALPABLE LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PALPABLE LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PALPABLE LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ONLINE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ONLINE DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY VALUE ADDED DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY VALUE ADDED DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 134. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 136. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 137. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 138. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 139. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 144. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 145. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 146. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 147. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 154. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rotary-Cutting Biopsy System for Breast Lesion market report include:
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Devicor Medical Products, Inc.
  • Merit Medical Systems, Inc.
  • Argon Medical Devices, Inc.
  • Cook Medical LLC
  • Cardinal Health, Inc.
  • Terumo Corporation
  • Misonix, Inc.
  • Medtronic plc